2021 annual financial data
REGENXBIO Inc. 2021 Net margin
REGENXBIO Inc. 2021 net margin with verified reported values.
Direct answer
Net margin was 27.18%.
Operating income was 159,980,000 USD and net income was 127,840,000 USD.
Operating cash flow was 218,875,000 USD.
Get free REGENXBIO Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 470,347,000 USD
- Operating income
- 159,980,000 USD
- Net income
- 127,840,000 USD
- Operating cash flow
- 218,875,000 USD